227 Single-Cell Sequencing of Human Choroid Plexus Identifies Novel Targets for Molecular Therapy of Hydrocephalus
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: Modulation of cerebrospinal fluid (CSF) production has significant implications in the management of neurosurgical disorders, most importantly hydrocephalus. There is little known about molecular targets of human choroid plexus to regulate CSF production. METHODS: Choroid plexus was acquired intraoperatively in patients undergoing intraventricular surgery. Specimens underwent single-cell sequencing (n = 10) and immunohistochemistry (n = 15). Choroid plexus epithelial cells (CPEC) were cultured in a two-chamber Transwell system. Immunofluorescence staining and lentiviral knockdown of molecular targets was conducted. Fluorescent dextran was used to measure fluid production. RESULTS: Choroid plexus sampling was safe and feasible in 15/15 patients. Specimens were confirmed to have classic morphology on H&E with positive transthyretin staining. Single-cell analysis of CPEC demonstrated high expression of sodium transporters and aquaporins including SLC4A10, ATP1A1 and AQP4. Immunohistochemistry showed strong expression of Na+/K+ ATPase and AQP4 on the apical surface. The Na+/HCO3- co-transporter SLC4A10 was the only transporter exclusively identified on the basolateral surface. CPEC cells were cultured on a Transwell model to confluence with positive transthyretin and SLC4A10 immunofluorescence. Preliminary data shows wildtype CPEC cells on the transwell model secrete 49 µL of fluid per hour and CPEC cells with lentiviral knockdown of SLC4A10 produce only 21 µL/hr on average. CONCLUSIONS: To the best of our knowledge, we have compiled the first single-cell database of fresh human choroid plexus samples and developed the first in vitro model of human choroid plexus capable of producing fluid. We identify SLC4A10 as a target for inhibiting CSF production by inhibiting Na+ import across the basolateral membrane, which subsequently decreases Na+/K+ ATPase- and AQP4-dependent CSF secretion across the apical membrane. Pharmacologic inhibition of molecular targets such as SLC4A10 may offer a non-operative treatment for hydrocephalus.
Fields of Study & Subjects
Cerebrospinal fluid and hydrocephalus
Ion Transport and Channel Regulation
Barrier Structure and Function Studies
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 52–52
- Publication date
- 26 March 2026
- Language
- EN